Publikationen 2011
Sclip A, Antoniou X, Colombo A, Camici GG, Pozzi L, Cardinetti D, Feligioni M, Veglianese P, Bahlmann FH, Cervo L, Balducci C, Costa C, Tozzi A, Calabresi P, Forloni G, Borsello T.
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model.
J Biol Chem 2011 Dec 23;286(51):43871-80. Impact Punkte: 5,3. Abstract
Rogacev KS, Bittenbring JT, Fliser D.
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.
N Engl J Med 2011 Nov 3;365(18):1745-6; author reply 6-7. Impact Punkte: 53,5. Abstract
Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, London GM, Zoccali C.
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.
Nat Rev Nephrol 2011;8(3):141-50. Impact Punkte: 4,8. Abstract
Seiler S, Cremers B, Rebling NM, Hornof F, Jeken J, Kersting S, Steimle C, Ege P, Fehrenz M, Rogacev KS, Scheller B, Bohm M, Fliser D, Heine GH.
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
Eur Heart J 2011 Nov;32(21):2688-96. Impact Punkte: 10,0. Abstract
Fliser D, Dellanna F, Koch M, Seufert J, Witzke O, Hauser IA.
The PRIMAVERA study protocol design: Evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease.
Contemp Clin Trials 2011 Nov;32(6):786-92. Impact Punkte: 1,2. Abstract
Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH.
SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.
Blood 2011 Sep 22;118(12):e50-61. Impact Punkte: 10,6. Abstract
Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, Faulhaber-Walter R, Haller H, Fliser D, Thum T.
Circulating miR-210 Predicts Survival in Critically Ill Patients with Acute Kidney Injury.
Clin J Am Soc Nephrol 2011 Jul;6(7):1540-6. Impact Punkte: 4,8. Abstract
Wagenlehner FM, Schmiemann G, Hoyme U, Funfstuck R, Hummers-Pradier E, Kaase M, Knieh E, Selbach I, Sester U, Vahlensieck W, Watermann D, Naber KG.
[S3-guideline for uncomplicated urinary tract infections - treatment guidelines compliance].
Med Monatsschr Pharm 2011 May;34(5):164-8. Abstract
Lorenzen JM, David S, Richter A, de Groot K, Kielstein JT, Haller H, Thum T, Fliser D.
TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
Nephrol Dial Transplant 2011 Apr;26(4):1421-4. Impact Punkte: 3,6. Abstract
Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, Lalvani A, Sester M.
Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states.
PLoS One 2011;6(3):e17813. Impact Punkte: 4,4. Artikel
Ulrich C, Seibert E, Heine GH, Fliser D, Girndt M.
Monocyte Angiotensin Converting Enzyme Expression May Be Associated with Atherosclerosis Rather than Arteriosclerosis in Hemodialysis Patients.
Clin J Am Soc Nephrol 2011 Mar;6(3):505-11. Impact Punkte: 4,8. Abstract
Wagenlehner FM, Schmiemann G, Hoyme U, Funfstuck R, Hummers-Pradier E, Kaase M, Kniehl E, Selbach I, Sester U, Vahlensieck W, Watermann D, Naber KG.
[National S3 guideline on uncomplicated urinary tract infection : Recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients.].
Urologe A 2011 Feb;50(2):153-69. Impact Punkte: 0,4. Abstract
Sorrentino SA, Doerries C, Manes C, Speer T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C, Schaefer A, Hilfiker-Kleiner D, Lüscher TF, Balligand JL, Drexler H, Landmesser U.
Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional beta(1)-Blockade.
J Am Coll Cardiol 2011 Feb 1;57(5):601-11. Impact Punkte: 14,3. Abstract
Lorenzen JM, Hafer C, Faulhaber-Walter R, Kumpers P, Kielstein JT, Haller H, Fliser D.
Osteopontin predicts survival in critically ill patients with acute kidney injury.
Nephrol Dial Transplant 2011 Feb;26(2):531-7. Impact Punkte: 3,6. Abstract
Dellanna F, Winkler RE, Bozkurt F, Schettler V, Graf S, Bockreiss N, Fliser D, on behalf of the MSG.
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study.
Int J Clin Pract 2011 Jan;65(1):64-72. Impact Punkte: 2,3. Abstract
Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH.
CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
Eur Heart J 2011 Jan;32(1):84-92. Impact Punkte: 10,0. Abstract
